Field | Row 1 |
---|---|
adsh | 0001437749-25-017025 |
cik | 1507957 |
name | IDEAL POWER INC. |
sic | 3674 |
countryba | US |
stprba | TX |
cityba | AUSTIN |
zipba | 78735 |
bas1 | 5508 HIGHWAY 290 WEST |
bas2 | SUITE 120 |
baph | 512-264-1542 |
countryma | US |
stprma | TX |
cityma | AUSTIN |
zipma | 78735 |
mas1 | 5508 HIGHWAY 290 WEST |
mas2 | SUITE 120 |
countryinc | US |
stprinc | DE |
ein | 141999058 |
former | IDEAL POWER CONVERTERS, INC. |
changed | 20101215 |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250515 |
accepted | 2025-05-15 09:31:00.0 |
prevrpt | 0 |
detail | 1 |
instance | ipwr20250331_10q_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001437749-25-017025 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 384595.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Common Stock Shares Outstanding | 8347970.0000 | shares | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Common Stock Value | 8337.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | General And Administrative Expense | 853688.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Increase Decrease In Operating Lease Liability | -16980.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Interest Income Expense Net | 121808.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Net Cash Provided By Used In Operating Activities | -2066774.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Operating Income Loss | -2526951.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Operating Income Loss | -2824832.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Operating Lease Liability Noncurrent | 403335.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Operating Lease Liability Noncurrent | 381128.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Operating Lease Right Of Use Asset | 462621.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Other Assets Noncurrent | 19351.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Other Liabilities Noncurrent | 989667.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 9346.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Payments To Acquire Intangible Assets | 73939.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Prepaid Expense And Other Assets Current | 356658.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Selling And Marketing Expense | 316611.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Shares Outstanding | 7382699.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20250331 | Stockholders Equity | -110170287.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Shares New Issues | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 8.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20231231 | Treasury Stock Common Shares | 1321.0000 | shares | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Treasury Stock Common Shares | 1321.0000 | shares | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20241231 | Treasury Stock Common Shares | 1321.0000 | shares | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 9101851.0000 | shares | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Accounts Payable Current | 155707.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Accrued Liabilities Current | 374012.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Assets | 19826684.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 8474835.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Common Stock Shares Issued | 8349291.0000 | shares | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Common Stock Value | 8349.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | General And Administrative Expense | 899821.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Increase Decrease In Operating Lease Liability | -19618.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Net Income Loss | -2469626.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20240331 | Operating Expenses | 2537192.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Operating Lease Right Of Use Asset | 483497.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Prepaid Expense And Other Assets Current | 313034.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 78739.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20231231 | Stockholders Equity | 10059700.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Stockholders Equity | 15527389.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Stockholders Equity | -13210.0000 | USD | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value New Issues | 1367.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 12.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20241231 | Accounts Receivable Net Current | 692.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -2145998.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Finite Lived Intangible Assets Net | 2611998.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Increase Decrease In Accounts Payable | -23086.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -44405.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Inventory Net | 89337.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Liabilities | 2066991.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Liabilities And Stockholders Equity | 19826684.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Liabilities Current | 560810.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20250331 | Operating Expenses | 2805973.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240430 | Operating Lease Right Of Use Asset | 524025.0000 | USD | 0 | us-gaap/2025 | Lease Contractual Term= Amended Lease; | ||
0001437749-25-017025 | 20250331 | Other Assets Noncurrent | 18570.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Payments To Acquire Property Plant And Equipment | 29611.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Proceeds From Issuance Of Common Stock | 13652663.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Property Plant And Equipment Net | 415232.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Property Plant And Equipment Net | 389579.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Retained Earnings Accumulated Deficit | -110170287.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 12003.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20231231 | Stockholders Equity | 107116362.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20240331 | Stockholders Equity | -99519076.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20250331 | Stockholders Equity | 8349.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 9679.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20241231 | Treasury Stock Common Shares | 1321.0000 | shares | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 6319939.0000 | shares | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Assets Current | 14107758.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 20235410.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 13696852.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 11760575.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Cost Of Revenue | 30862.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Gross Profit | 10241.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Gross Profit | -18859.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Impairment Of Long Lived Assets Held For Use | 10217.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Increase Decrease In Accounts Receivable | 70000.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Increase Decrease In Inventories | 27912.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Liabilities Current | 696196.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Net Cash Provided By Used In Investing Activities | -69878.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Net Income Loss | -2703024.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 16157.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Shares Outstanding | 8349291.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20231231 | Stockholders Equity | 5998.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20231231 | Stockholders Equity | -97049450.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20241231 | Stockholders Equity | 125327300.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Shares New Issues | 1366668.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value New Issues | 13652663.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -9358.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20241231 | Accounts Payable Current | 104117.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Additional Paid In Capital | 125327300.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Additional Paid In Capital | 125702537.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Cash And Cash Equivalents At Carrying Value | 13696852.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 15842850.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Depreciation Depletion And Amortization | 90476.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Earnings Per Share Basic | -0.3000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Interest Income Expense Net | 57325.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Liabilities | 1971520.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Liabilities And Stockholders Equity | 17594380.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Net Cash Provided By Used In Financing Activities | 13739420.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Net Cash Provided By Used In Operating Activities | -1875295.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Research And Development Expense | 1567992.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Stockholders Equity | 125702537.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -9346.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 86757.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 381019.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20241231 | Cash And Cash Equivalents At Carrying Value | 15842850.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
0001437749-25-017025 | 20241231 | Common Stock Shares Outstanding | 8335491.0000 | shares | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Depreciation Depletion And Amortization | 81121.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Finite Lived Intangible Assets Net | 2615852.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Impairment Of Long Lived Assets Held For Use | 1201.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Increase Decrease In Accounts Payable | 51590.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Increase Decrease In Accounts Receivable | 7843.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 63499.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Net Income Loss | -2469626.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20241231 | Operating Lease Liability Current | 82681.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 20876.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Payments To Acquire Intangible Assets | 58554.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Share Based Compensation | 384595.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20231231 | Stockholders Equity | -13210.0000 | USD | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Stockholders Equity | 7383.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20241231 | Stockholders Equity | 17855164.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Stockholders Equity | 8337.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20241231 | Stockholders Equity | -13210.0000 | USD | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 8334.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -10.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 86749.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20250331 | Treasury Stock Common Shares | 1321.0000 | shares | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20250331 | Accrued Liabilities Current | 455219.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 381019.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 384595.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Assets | 17594380.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Assets Current | 16296606.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Cost Of Revenue | 68498.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Earnings Per Share Basic | -0.3900 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 32357.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Inventory Net | 96406.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20241231 | Other Liabilities Noncurrent | 1007375.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Payments To Acquire Property Plant And Equipment | 11324.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Proceeds From Stock Options Exercised | 86757.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Proceeds From Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Research And Development Expense | 1366893.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Retained Earnings Accumulated Deficit | -107467263.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20241231 | Shares Outstanding | 8336812.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20240331 | Stockholders Equity | 121235416.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20240331 | Stockholders Equity | -13210.0000 | USD | 0 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20241231 | Stockholders Equity | -107467263.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value New Issues | 13651296.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 10.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20250331 | Treasury Stock Common Shares | 1321.0000 | shares | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Treasury Stock Common Value | 13210.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Accounts Receivable Net Current | 8535.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20241231 | Common Stock Shares Issued | 8336812.0000 | shares | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Increase Decrease In Inventories | -7069.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -211438.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Net Cash Provided By Used In Financing Activities | -9346.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Net Cash Provided By Used In Investing Activities | -103550.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Net Income Loss | -2703024.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20250331 | Operating Lease Liability Current | 85270.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Selling And Marketing Expense | 338160.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20240331 | Share Based Compensation | 381019.0000 | USD | 1 | us-gaap/2025 | |||
0001437749-25-017025 | 20231231 | Shares Outstanding | 5998018.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20240331 | Stockholders Equity | 21710513.0000 | USD | 0 | us-gaap/2025 | |||
0001437749-25-017025 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 12479.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Treasury Stock Common; | ||
0001437749-25-017025 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001437749-25-017025 | 20241231 | Treasury Stock Common Value | 13210.0000 | USD | 0 | us-gaap/2025 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Proceeds From Issuance Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Interest Income Expense Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Income (Expense), Operating | Amount of interest income (expense) classified as operating. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
Payments To Acquire Intangible Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Intangible Assets | The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. |
Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
Depreciation Depletion And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
Finite Lived Intangible Assets Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Other Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
Selling And Marketing Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Payments To Acquire Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. |
Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
Increase Decrease In Inventories | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. | |
Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Impairment Of Long Lived Assets Held For Use | us-gaap/2025 | 0 | 0 | monetary | D | D | Impairment, Long-Lived Asset, Held-for-Use | The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). |
Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
Inventory Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Treasury Stock Common Shares | us-gaap/2025 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. | |
Treasury Stock Common Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Treasury Stock, Common, Value | Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury. |
Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Proceeds From Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
Revenue From Contract With Customer Including Assessed Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Including Assessed Tax | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. |
Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001437749-25-017025 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
0001437749-25-017025 | 2 | 4 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
0001437749-25-017025 | 2 | 5 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Accounts receivable, net | 0 |
0001437749-25-017025 | 2 | 6 | BS | 0 | H | Inventory Net | us-gaap/2025 | Inventory | 0 |
0001437749-25-017025 | 2 | 7 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepayments and other current assets | 0 |
0001437749-25-017025 | 2 | 8 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
0001437749-25-017025 | 2 | 9 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
0001437749-25-017025 | 2 | 10 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2025 | Intangible assets, net | 0 |
0001437749-25-017025 | 2 | 11 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Right of use asset | 0 |
0001437749-25-017025 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other assets | 0 |
0001437749-25-017025 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
0001437749-25-017025 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
0001437749-25-017025 | 2 | 16 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
0001437749-25-017025 | 2 | 17 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Current portion of lease liability | 0 |
0001437749-25-017025 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
0001437749-25-017025 | 2 | 19 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Long-term lease liability | 0 |
0001437749-25-017025 | 2 | 20 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2025 | Other long-term liabilities | 0 |
0001437749-25-017025 | 2 | 21 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
0001437749-25-017025 | 2 | 22 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and Contingencies | 0 |
0001437749-25-017025 | 2 | 24 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.001 par value; 50,000,000 shares authorized; 8,349,291 shares issued and 8,347,970 shares outstanding at March 31, 2025 and 8,336,812 shares issued and 8,335,491 shares outstanding at December 31, 2024 | 0 |
0001437749-25-017025 | 2 | 25 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
0001437749-25-017025 | 2 | 26 | BS | 0 | H | Treasury Stock Common Value | us-gaap/2025 | Treasury stock, at cost, 1,321 shares at March 31, 2025 and December 31, 2024 | 0 |
0001437749-25-017025 | 2 | 28 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
0001437749-25-017025 | 2 | 29 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders equity | 0 |
0001437749-25-017025 | 3 | 3 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common Stock, Par or Stated Value Per Share (in dollars per share) | 0 |
0001437749-25-017025 | 3 | 4 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common Stock, Shares Authorized (in shares) | 0 |
0001437749-25-017025 | 3 | 5 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common Stock, Shares, Issued (in shares) | 0 |
0001437749-25-017025 | 3 | 6 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common Stock, Shares, Outstanding (in shares) | 0 |
0001437749-25-017025 | 3 | 7 | BS | 1 | H | Treasury Stock Common Shares | us-gaap/2025 | Treasury Stock, Common, Shares (in shares) | 0 |
0001437749-25-017025 | 4 | 3 | IS | 0 | H | Revenue From Contract With Customer Including Assessed Tax | us-gaap/2025 | Revenue | 0 |
0001437749-25-017025 | 4 | 4 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | Cost of revenue | 0 |
0001437749-25-017025 | 4 | 5 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross profit (loss) | 0 |
0001437749-25-017025 | 4 | 7 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development | 0 |
0001437749-25-017025 | 4 | 8 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
0001437749-25-017025 | 4 | 9 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2025 | Sales and marketing | 0 |
0001437749-25-017025 | 4 | 10 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
0001437749-25-017025 | 4 | 11 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operations | 0 |
0001437749-25-017025 | 4 | 12 | IS | 0 | H | Interest Income Expense Net | us-gaap/2025 | Interest income, net | 0 |
0001437749-25-017025 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
0001437749-25-017025 | 4 | 14 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Net loss per share basic and diluted (in dollars per share) | 0 |
0001437749-25-017025 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average number of shares outstanding basic and diluted (in shares) | 0 |
0001437749-25-017025 | 5 | 4 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
0001437749-25-017025 | 5 | 6 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
0001437749-25-017025 | 5 | 7 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | Amortization of right of use asset | 0 |
0001437749-25-017025 | 5 | 8 | CF | 0 | H | Impairment Of Long Lived Assets Held For Use | us-gaap/2025 | Write-off of property and equipment | 0 |
0001437749-25-017025 | 5 | 9 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation | 0 |
0001437749-25-017025 | 5 | 10 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Accounts receivable | 1 |
0001437749-25-017025 | 5 | 11 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2025 | Inventory | 0 |
0001437749-25-017025 | 5 | 12 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other assets | 1 |
0001437749-25-017025 | 5 | 13 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
0001437749-25-017025 | 5 | 14 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2025 | Accrued expenses and other liabilities | 0 |
0001437749-25-017025 | 5 | 15 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Lease liability | 0 |
0001437749-25-017025 | 5 | 16 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
0001437749-25-017025 | 5 | 18 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2025 | Purchase of property and equipment | 1 |
0001437749-25-017025 | 5 | 19 | CF | 0 | H | Payments To Acquire Intangible Assets | us-gaap/2025 | Acquisition of intangible assets | 1 |
0001437749-25-017025 | 5 | 20 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash used in investing activities | 0 |
0001437749-25-017025 | 5 | 22 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | Payment of taxes upon vesting of restricted stock units | 1 |
0001437749-25-017025 | 5 | 23 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2025 | Net proceeds from issuance of common stock and pre-funded warrants | 0 |
0001437749-25-017025 | 5 | 24 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2025 | Exercise of options and warrants | 0 |
0001437749-25-017025 | 5 | 25 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
0001437749-25-017025 | 5 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Net increase (decrease) in cash and cash equivalents | 0 |
0001437749-25-017025 | 5 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | Cash and cash equivalents at beginning of period | 0 |
0001437749-25-017025 | 5 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | Cash and cash equivalents at end of period | 0 |
0001437749-25-017025 | 6 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balances (in shares) | 0 |
0001437749-25-017025 | 6 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balances | 0 |
0001437749-25-017025 | 6 | 11 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2025 | Balances (in shares) | 0 |
0001437749-25-017025 | 6 | 12 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Issuance of common stock and pre-funded warrants (in shares) | 0 |
0001437749-25-017025 | 6 | 13 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Issuance of common stock and pre-funded warrants | 0 |
0001437749-25-017025 | 6 | 14 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | Exercise of options (in shares) | 0 |
0001437749-25-017025 | 6 | 15 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | Exercise of options | 0 |
0001437749-25-017025 | 6 | 16 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2025 | Vesting of restricted stock units (in shares) | 0 |
0001437749-25-017025 | 6 | 17 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2025 | Vesting of restricted stock units | 0 |
0001437749-25-017025 | 6 | 18 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Stock-based compensation | 0 |
0001437749-25-017025 | 6 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
0001437749-25-017025 | 6 | 20 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Stock-based compensation | 0 |
0001437749-25-017025 | 6 | 21 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balances (in shares) | 0 |
0001437749-25-017025 | 6 | 22 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balances | 0 |
0001437749-25-017025 | 6 | 23 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2025 | Balances (in shares) | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |